Multivariate Cox proportional hazards regression modeling determined that both MPN subtype and CD68/CD163 macrophage polarization ratio were independent predictors of thrombosis timing in our cohort, supporting the clinical relevance of incorporating this biomarker into routine risk assessment algorithms. The gene discussed is CD68; the disease is myeloproliferative neoplasm.